HomeNewsVideos

Pyridam Farma issues Bonds of IDR 400 billion

14 February 2022 09:25

JAKARTA – PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, is currently offering the Shelf-Registered Bond Phase I Year 2022 of IDR 400 billion from last week until this very day (11-14/2). The bonds are offered with a five-year tenor and interest payment per three months.

In the short prospectus quoted on Monday (14/2), it was said that 90% of the proceeds from the corporate action would be spent on developing the business, while another 10% would go to the working capital. The projected business development includes acquiring a food and beverages company, buying supporting machines for the company’s facilities, upgrading the technology in the operational scope, and renovating the building.

PT Kredit Rating Indonesia has granted a “BBB+ (Triple B plus)” rating to PYFA regarding this plan. The assigned underwriter is PT Aldiracita Sekuritas Indonesia, while the appointed trustee is PT Bank KB Bukopin Tbk (BBKP). (LK/ZH)

© 2024 - IDN Financials - All Rights Reserved.